03/12/2024
VIPColonoscopy.vip
The 10 things that make us different:
1. We review every recall. Up to 40% of patients are NOT due based on updated guidelines.
2. We educate the patient and their P*P on the role of molecular stool testing and those which will be approved soon. This will increase access and improve outcomes individually and from a public health perspective. Only 57% of the US gets screened currently. However, the issues with stool tests are important to recognize. For example, Cologuard was not validated in age